M&A Tag

The British drugmaker AstraZeneca reportedly has hired Goldman Sachs and Morgan Stanley to advise it on any renewed takeover interest offer from Pfizer, after it emerged that the US giant had approached AZ regarding a potential £60bn tie-up. Although the pharmaceutical groups are not thought to...

Big-cap pharma deals have returned in force to the European mergers and acquisition landscape after Novartis has moved to simplify its corporate structure. Seven investment banks have bagged a role on three separate transactions as the Swiss pharmaceuticals giant and UK-listed GlaxoSmithKline have agreed to swap...

Global acquisitions by corporate acquirers have hit the second highest year-to-date volume on record with deals valued at US$764.3bn this year – up 71% on the 2013 YTD level of US$446.5bn – and accounting for 77% of the overall M&A volume so far this year,...

BlackBerry has bought a stake in NantHealth, the US healthcare IT company, in a move that the struggling smartphone company hopes will enable it to exploit its network-security expertise and real-time operating systems technology in a potentially massive market. The deal, the terms of which were...

Accounting for 33% of total M&A activity this year, cross border M&A totalled US$235.2bn during the first quarter of this year, 78% higher than a year ago (US$132bn) and bolstered by the US$23.3bn offer from the Ireland-based drugmaker Actavis for Forest Laboratories of the US...